We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+14.57%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$6.85B
AUM Growth
-$481M
Cap. Flow
-$845M
Cap. Flow %
-12.34%
Top 10 Hldgs %
41.03%
Holding
120
New
33
Increased
27
Reduced
18
Closed
27

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.56%
2 Healthcare 9.88%
3 Technology 9.5%
4 Communication Services 8.84%
5 Industrials 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALTR
51
DELISTED
Altera Corp
ALTR
$20.2M 0.29%
+470,000
New +$16.8M
HLSS
52
DELISTED
HOME LN SERVICING SOLUTIONS LTD(CAYMAN ISLANDS)
HLSS
$20.1M 0.29%
+1,216,000
New +$20M
NVET
53
DELISTED
Nexvet Biopharma plc Ordinary Shares
NVET
$20.1M 0.29%
+2,499,996
New +$23.7M
ESRX
54
DELISTED
Express Scripts Holding Company
ESRX
$19.4M 0.28%
223,000
-362,000
-62% -$30.4M
AXLL
55
DELISTED
AXIALL CORP COM STK (DE)
AXLL
$18.5M 0.27%
394,890
-117,110
-23% -$5.28M
BABA icon
56
Alibaba
BABA
$303B
$18.4M 0.27%
+221,000
New +$19.9M
WMGI
57
DELISTED
Wright Medical Group Inc
WMGI
$16.9M 0.25%
655,000
+231,000
+54% +$5.95M
XLS
58
DELISTED
EXELIS INC COM STK
XLS
$16M 0.23%
+655,000
New +$14M
ARUN
59
DELISTED
ARUBA NETWORKS, INC.
ARUN
$14.7M 0.21%
+600,000
New +$12.1M
OVTI
60
DELISTED
OMNIVISION TECHNOLOGIES INC
OVTI
$14.3M 0.21%
540,871
+165,871
+44% +$4.44M
TEG
61
DELISTED
INTEGRYS ENERGY GROUP INC COM (USA)
TEG
$13.4M 0.2%
+185,719
New +$14.2M
OREX
62
DELISTED
Orexigen Therapeutics, Inc.
OREX
$11.5M 0.17%
146,700
-47,000
-24% -$2.92M
CBL
63
DELISTED
CBL& Associates Properties, Inc.
CBL
$11.1M 0.16%
560,000
LTM
64
DELISTED
LIFE TIME FITNESS INC
LTM
$10.6M 0.16%
+150,000
New +$9.01M
KMI.WS
65
DELISTED
Kinder Morgan Inc
KMI.WS
$10.3M 0.15%
2,500,000
INFA
66
DELISTED
INFORMATICA CORP
INFA
$10.1M 0.15%
+230,000
New +$9.57M
STML
67
DELISTED
Stemline Therapeutics, Inc.
STML
$9.73M 0.14%
672,562
+577,562
+608% +$8.84M
TTPH
68
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$9.64M 0.14%
+13,150
New +$9.88M
LPG icon
69
Dorian LPG
LPG
$1.91B
$9.58M 0.14%
735,529
GRFS
70
Grifois
GRFS
$5.34B
$9.51M 0.14%
+579,376
New +$9.7M
RCPT
71
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$9.32M 0.14%
56,500
-108,500
-66% -$13.7M
INXN
72
DELISTED
Interxion Holding N.V.
INXN
$9.31M 0.14%
+330,000
New +$9.67M
PCO
73
DELISTED
Pendrell Corporation - Class A
PCO
$8.8M 0.13%
6,768
BGC
74
DELISTED
General Cable Corporation
BGC
$7.55M 0.11%
+438,050
New +$6.2M
MIG
75
DELISTED
MEADOWBROOK INSURANCE GRP INC
MIG
$5.99M 0.09%
+704,617
New +$5.91M

Similar funds

Farallon Capital Management's Q1 2015 Portfolio in Review

As of Q1 2015, Farallon Capital Management held 120 positions worth $6.85B, down 6.6% from $7.33B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Farallon Capital Management withdrew a net $845M in Q1 2015, closing 27 positions and reducing 18 holdings. Its most notable exit was Allergan Inc, an estimated $531M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Farallon Capital Management opened a new position in PHARMACYCLICS INC worth $498M.

  • Farallon Capital Management's largest Q1 2015 buy was PHARMACYCLICS INC: 1,945,000 shares worth $498M.
  • Farallon Capital Management added most to Allergan plc in Q1 2015, an estimated $262M increase.
  • Farallon Capital Management's biggest Q1 2015 reduction was Coca-Cola Europacific Partners, cutting an estimated $123M.
  • Farallon Capital Management fully exited Allergan Inc in Q1 2015, selling an estimated $531M.
  • Farallon Capital Management's ten largest holdings make up 41% of its $6.85B portfolio in Q1 2015.
  • Farallon Capital Management opened 33 new positions and closed 27 in Q1 2015.
  • Farallon Capital Management's portfolio value fell 6.6% quarter-over-quarter to $6.85B.

Based on Farallon Capital Management's 13F filing for Q1 2015, filed 15 May 2015.